Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIRX
3401
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $46.1K | ﹤0.01% |
286,395
+40,996
| +17% | +$8.07K |
|
|
NURO
3402
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $45.9K | ﹤0.01% |
+11,560
| New | +$46.8K |
|
3403
Planet Green Holdings
PLAG
$16.1M
| $45.7K | ﹤0.01% |
+17,600
| New | +$42K |
|
3404
Metalpha Technology Holding
MATH
$38.5M
| $45.7K | ﹤0.01% |
39,700
-400
| -1% | -$438 |
|
3405
Bionano Genomics
BNGO
$13.5M
| $45.7K | ﹤0.01% |
+2,638
| New | +$45.1K |
|
3406
ICZOOM Group
IZM
$3M
| $44.4K | ﹤0.01% |
26,300
-28,153
| -52% | -$63K |
|
3407
CLPS Inc
CLPS
$26.1M
| $43.6K | ﹤0.01% |
37,269
+24,237
| +186% | +$29.9K |
|
3408
Dyadic International
DYAI
$28.1M
| $43.6K | ﹤0.01% |
24,900
+1,900
| +8% | +$2.6K |
|
|
TWAV
3409
TaoWeave Inc
TWAV
$5.16M
| $43.1K | ﹤0.01% |
+11,100
| New | +$41.2K |
|
|
VSTA
3410
DELISTED
Vasta Platform
VSTA
| $42.6K | ﹤0.01% |
21,300
-1,200
| -5% | -$2.94K |
|
|
BRNS
3411
Barinthus Biotherapeutics
BRNS
$24.5M
| $42.4K | ﹤0.01% |
35,100
+7,200
| +26% | +$8.38K |
|
|
WINT
3412
DELISTED
Windtree Therapeutics
WINT
| $41.7K | ﹤0.01% |
+2,385
| New | +$75.7K |
|
|
FNUC
3413
Frontier Nuclear and Minerals Inc
FNUC
$50.5M
| $41.4K | ﹤0.01% |
3,315
+2,453
| +285% | +$10.5K |
|
|
WCT
3414
Wellchange Holdings
WCT
$4.35M
| $40.7K | ﹤0.01% |
+848
| New | +$186K |
|
3415
Boxlight
BOXL
$4.54M
| $40.7K | ﹤0.01% |
592
+30
| +5% | +$2.39K |
|
|
BEDU
3416
DELISTED
Bright Scholar Education Holdings
BEDU
| $40.6K | ﹤0.01% |
23,625
-900
| -4% | -$1.71K |
|
|
MRDN
3417
Meridian Holdings Inc
MRDN
$178M
| $40.2K | ﹤0.01% |
1,692
-2,625
| -61% | -$73.1K |
|
|
BHIL
3418
DELISTED
Benson Hill, Inc.
BHIL
| $39.9K | ﹤0.01% |
20,263
-200
| -1% | -$1.01K |
|
|
RTB
3419
RTB Digital
RTB
$236M
| $39.5K | ﹤0.01% |
868
+163
| +23% | +$8.96K |
|
|
STRR
3420
DELISTED
Star Equity Holdings
STRR
| $39.5K | ﹤0.01% |
17,460
+4,718
| +37% | +$15.3K |
|
3421
CollPlant Biotechnologies
CLGN
$6.02M
| $38.2K | ﹤0.01% |
+10,600
| New | +$43.1K |
|
3422
Lexicon Pharmaceuticals
LXRX
$1.04B
| $37.8K | ﹤0.01% |
+51,141
| New | +$61.6K |
|
|
QTEX
3423
QTREX Quantum
QTEX
$55.7M
| $37.4K | ﹤0.01% |
36,622
+21,532
| +143% | +$27.5K |
|
|
YQ
3424
17 Education & Technology Group
YQ
$23.2M
| $36.9K | ﹤0.01% |
23,230
+2,500
| +12% | +$5.09K |
|
|
FENG
3425
Phoenix New Media
FENG
$18.4M
| $36.6K | ﹤0.01% |
15,431
-6,500
| -30% | -$17.6K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.